Professional Documents
Culture Documents
Full download Benzodiazepine-Based Drug Discovery Farzad Zamani file pdf all chapter on 2024
Full download Benzodiazepine-Based Drug Discovery Farzad Zamani file pdf all chapter on 2024
Farzad Zamani
Visit to download the full and correct content document:
https://ebookmass.com/product/benzodiazepine-based-drug-discovery-farzad-zamani
/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://ebookmass.com/product/imidazole-based-drug-discovery-
heterocyclic-drug-discovery-shikha-agarwal/
https://ebookmass.com/product/piperidine-based-drug-discovery-
ruben-vardanyan/
https://ebookmass.com/product/peptide-based-drug-discovery-
challenges-and-new-therapeutics-issn-book-59-1st-edition-ebook-
pdf/
https://ebookmass.com/product/discovery-and-development-of-
antidiabetic-agents-from-natural-products-natural-product-drug-
discovery-goutam-brahmachari/
Applications of Nanotechnology in Drug Discovery and
Delivery Chukwuebuka Egbuna
https://ebookmass.com/product/applications-of-nanotechnology-in-
drug-discovery-and-delivery-chukwuebuka-egbuna/
https://ebookmass.com/product/medicinal-plants-of-south-asia-
novel-sources-for-drug-discovery-hanif/
https://ebookmass.com/product/high-throughput-mass-spectrometry-
in-drug-discovery-1-edition-chang-liu/
https://ebookmass.com/product/small-molecule-drug-discovery-
methods-molecules-and-applications-1st-edition-andrea-trabocchi-
editor/
https://ebookmass.com/product/alpha-glucosidase-inhibitors-
clinically-promising-candidates-for-anti-diabetic-drug-discovery-
usman-ghani/
BENZODIAZEPINE-BASED
DRUG DISCOVERY
Heterocyclic Drug Discovery Series
BENZODIAZEPINE-BASED
DRUG DISCOVERY
FARZAD ZAMANI
SANKEN, Osaka University, Mihogaoka, Ibaraki-shi, Osaka, Japan
ESMAIL DOUSTKHAH
Koç University Tüpraş Energy Center (KUTEM), Department of Chemistry,
Koç University, Istanbul, Turkey
Series Editor
RUBEN VARDANYAN
Elsevier
Radarweg 29, PO Box 211, 1000 AE Amsterdam, Netherlands
The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States
No part of this publication may be reproduced or transmitted in any form or by any means,
electronic or mechanical, including photocopying, recording, or any information storage
and retrieval system, without permission in writing from the publisher. Details on how to
seek permission, further information about the Publisher’s permissions policies and our
arrangements with organizations such as the Copyright Clearance Center and the
Copyright Licensing Agency, can be found at our website: www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright
by the Publisher (other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and
experience broaden our understanding, changes in research methods, professional practices,
or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in
evaluating and using any information, methods, compounds, or experiments described
herein. In using such information or methods they should be mindful of their own safety
and the safety of others, including parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or
editors, assume any liability for any injury and/or damage to persons or property as a matter
of products liability, negligence or otherwise, or from any use or operation of any methods,
products, instructions, or ideas contained in the material herein.
ISBN: 978-0-12-824516-3
Fatemeh Ahmadi
Department of Materials Science, Science and Research Branch, Islamic Azad University,
Tehran, Iran
Elaheh Akbarzadeh
Department of Organic Chemistry, Faculty of Chemistry, Kharazmi University, Tehran, Iran
Fatemeh M. Arlan
Department of Chemistry, Academic Center for Education, Culture and Research, Urmia,
Iran
Ronald W. Brown
Bayer AG, Frankfurt am Main, Germany
Esmail Doustkhah
Koç University, Tüpraş Energy Center (KUTEM), Department of Chemistry, Koç
University, Istanbul, Turkey
Mohammad Heidarizadeh
Department of Biotechnology, Faculty of Biological Science and Technology, University of
Isfahan, Isfahan, Iran
Christopher J.T. Hyland
School of Chemistry and Molecular Bioscience, University of Wollongong, Wollongong,
NSW, Australia
Arash Janaty
Department of Biological Sciences and Biotechnology, Faculty of Sciences, University of
Kurdistan, Sanandaj, Iran
Ramin Javahershenas
Department of Organic Chemistry, Urmia University, Urmia, Iran
Rafael Luque
Departamento de Quimica Organica, Universidad de Córdoba, Campus de Rabanales,
Edificio Marie Curie, Córdoba, Spain.
Saeedeh Mohammadi
Department of Physics, Shahid Rajaee Teacher Training University, Lavizan, Tehran, Iran
Zahra Nikfarjam
Chemistry and Chemical Engineering Research Center of Iran (CCERCI), Tehran, Iran
Takayoshi Suzuki
SANKEN, Osaka University, Mihogaoka, Ibaraki-shi, Osaka, Japan
Abtin Tavakoli
Department of Biological Sciences and Biotechnology, Faculty of Sciences, University of
Kurdistan, Sanandaj, Iran
ix
x Contributors
Rajender S. Varma
Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology
and Research Institute, Palacký University in Olomouc, Olomouc, Czech Republic
Masoud Yarmohammadi
Faculty of Mechanical Engineering-Energy Division, K.N. Toosi University of Technology,
Tehran, Iran
Farzad Zamani
SANKEN, Osaka University, Mihogaoka, Ibaraki-shi, Osaka, Japan
Nasrin Zamani
Growth and Development Research Center, Tehran University of Medical Sciences,
Tehran, Iran
Contents
Contributors ix
Preface xi
Acknowledgment xiii
v
vi Contents
Index 321
Preface
xi
Acknowledgment
xiii
CHAPTER ONE
An introduction to
benzodiazepines and
benzothiazepines
Farzad Zamania and Esmail Doustkhahb
a
SANKEN, Osaka University, Mihogaoka, Ibaraki-shi, Osaka, Japan
b
Koç University Tüpraş Energy Center (KUTEM), Department of Chemistry, Koç University, Istanbul,
Turkey
Chapter outline
1.1 Benzodiazepines 1
1.2 Benzothiazepines 4
References 5
1.1 Benzodiazepines
Benzodiazepines as pharmaceutical compounds have emerged as a
powerful tool for curing anxiety disorders.According to a national 12-month
survey conducted by the US National Comorbidity Survey Replication
(NCS-R) and the National Institute of Mental Health (NIMH), approxi-
mately 40% of people in the US suffer from generalized anxiety disorder
(GAD), panic disorder, post-traumatic stress disorder (PTSD), obsessive-
compulsive disorder (OCD), or any other types of mental ailments (Kessler,
Chiu, Demler, & Walters, 2005). Traditional clinical treatments for anxiety
comprised of consuming general sedatives such as opiates, alcohol, chloral
hydrate, and lithium bromide. These anxiolytics however displayed limited
efficacy along with several drawbacks such as dizziness, impaired cognitive
functions, sexual dysfunction, death, and other adverse effects. In this regard,
the development of efficient treatments for anxiety disorders has always been
a hot topic in medicinal research.
Benzodiazepines (BDZs) are a family of bicyclic heterocycles consisting
of a benzene ring fused to a diazepine unit. According to Hantzsch–
Widman systematic chemical nomenclature recommended by The Inter-
national Union of Pure and Applied Chemistry (IUPAC), the “benzo”
prefix accounts for the benzene ring, and the diazepine refers to the seven-
membered heterocycle with two nitrogen and five carbon atoms forming
1.2 Benzothiazepines
Benzothiazepines structurally resemble benzodiazepines, composed
of bicyclic heterocycles consisting of a benzene unit fused to a thi-
azepine ring. Depending on the heteroatom’s position on the ring, dif-
ferent nomenclatures can possess. Among them, 1,4-benzothiazepines and
1,5-benzothiazepines are the most common structural isomers for these
heterocyclic scaffolds. The last 50 years have witnessed substantial progress
in the chemistry of benzothiazepines led to the synthesis of various analogs
and the discovery of their biological activities. These versatile skeletons have
represented a wide range of therapeutic functions such as CNS depressant,
antimicrobial, antifungal, antiplatelet aggregation, anti-HIV, Ca+2 antagonist,
calmodulin antagonist, and bradykinin receptor antagonist activities (Bariwal
et al., 2008; Saha et al., 2015). The first example of benzodiazepines in-
troduced into the pharmaceutical market was thiazesim (Altinil, 1.2.1) as
an antipsychotic agent for CNS disorders (Geyer et al., 1970), followed by
diltiazem (Cardizem, 1.2.2) developed as a cardiovascular drug of this family
(Fig. 1.2) (Nagao et al., 1972). Benzothiazepines, which are bioisosters of
An introduction to benzodiazepines and benzothiazepines 5
References
Agarwal, S. D., & Landon, B. E. (2019). Patterns in outpatient benzodiazepine prescribing
in the United States. JAMA Network Open, 2(1), e187399. https://doi.org/10.1001/
jamanetworkopen.2018.7399.
Bariwal, J. B., Upadhyay, K. D., Manvar, A. T., Trivedi, J. C., Singh, J. S., Jain, K. S., &
Shah, A. K. (2008). 1,5-Benzothiazepine, a versatile pharmacophore: a review. Euro-
pean Journal of Medicinal Chemistry, 43(11), 2279–2290. https://doi.org/10.1016/j.ejmech.
2008.05.035.
6 Farzad Zamani and Esmail Doustkhah
Brogden, R. N., & Goa, K. L. (1988). Flumazenil. A preliminary review of its benzodiazepine
antagonist properties, intrinsic activity and therapeutic use. Drugs, 35(4), 448–467.
https://doi.org/10.2165/00003495-198835040-00004.
Calcaterra, N. E., & Barrow, J. C. (2014). Classics in chemical neuroscience: Diazepam (valium).
ACS Chemical Neuroscience, 5(4), 253–260. https://doi.org/10.1021/cn5000056.
Geyer, H. M., Watzman, N., & Buckley, J. P. (1970). Effects of a tranquilizer and two
antidepressants on learned and unlearned behaviors. Journal of Pharmaceutical Sciences,
59(7), 964–968. https://doi.org/10.1002/jps.2600590709.
Kessler, R. C., Chiu, W. T., Demler, O., & Walters, E. E. (2005). Prevalence, severity, and comor-
bidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.
Archives of General Psychiatry, 62(6), 617−627. https://doi.org/10.1001/archpsyc.62.6.617.
Kuch, H. (1979). Clobazam: Chemical aspects of the 1,4- and 1,5-benzodiazepines.
British Journal of Clinical Pharmacology, 7(1), 17S–21S. https://doi.org/10.1111/j.1365-2125.
1979.tb04659.x.
Lader, M. (1991). History of benzodiazepine dependence. Journal of Substance Abuse Treatment,
8(1–2), 53–59. https://doi.org/10.1016/0740-5472(91)90027-8.
Lader, M. (2011). Benzodiazepines revisited - will we ever learn? Addiction, 106(12), 2086–2109.
https://doi.org/10.1111/j.1360-0443.2011.03563.x.
Lassen, N. A., Bartenstein, P. A., Lammertsma, A. A., Prevett, M. C., Turton, D. R., Luthra, S. K.,
... Patsalos, P. N. (1995). Benzodiazepine receptor quantification in vivo in humans using
[11 C]flumazenil and PET: application of the steady-state principle. Journal of Cerebral Blood
Flow and Metabolism, 15(1), 152–165. https://doi.org/10.1038/jcbfm.1995.17.
Nagao, T., Sato, M., Iwasawa, Y., Takada, T., & Ishida, R. (1972). Studies on a new 1,5-
benzothiazepine derivative (CRD-401). 3. Effects of optical isomers of CRD-401 on
smooth muscle and other pharmacological properties. Japanese Journal of Pharmacology,
22(4), 467–478. https://doi.org/10.1254/jjp.22.467.
Nemeroff, C. B. (2003). The role of GABA in the pathophysiology and treatment of anxiety
disorders. Psychopharmacology Bulletin, 37(4), 133–146.
Nikalje, A. P. G., Ghodke, M. S., Khan, F. A. K., & Sangshetti, J. N. (2016). Microwave assisted
facile synthesis and biological evaluation of novel 2-indolyl-1,5-benzothiazepines. Open
Pharmaceutical Sciences Journal, 6, 117–130. https://doi.org/10.2174/1874844901603010117.
Nutt, D. J., & Malizia, A. L. (2001). New insights into the role of the GABAA -
benzodiazepine receptor in psychiatric disorder. British Journal of Psychiatry, 179(5), 390–
396. https://doi.org/10.1192/bjp.179.5.390.
Parjane, S. K., Kunkulol, R., & Nandal, D. (2020). Synthesis of some novel 1,5-benzothiazepine
derivatives biological screening for anticonvulsant activity. IOSR Journal of Applied
Chemistry, 13(3), 50–55. https://doi.org/10.9790/5736-1303015055.
Penninkilampi, R., & Eslick, G. D. (2018). A systematic review and meta-analysis of the risk
of dementia associated with benzodiazepine use, after controlling for protopathic bias.
CNS Drugs, 32, 485–497. https://doi.org/10.1007/s40263-018-0535-3.
Polc, P., Mohler, H., & Haefely, W. (1974). The effect of diazepam on spinal cord activities:
Possible sites and mechanisms of action. Naunyn-Schmiedeberg’s Archives of Pharmacology,
284, 319–337. https://doi.org/10.1007/BF00504702.
Saha, D., Jain, G., & Sharma, A. (2015). Benzothiazepines: chemistry of a privileged scaffold.
RSC Advances, 5(86), 70619–70639. https://doi.org/10.1039/C5RA12422K.
Samardzic, J., & Strac, D. S. (2016). Benzodiazepines and anxiety disorders: from laboratory to
clinic. In F. Durbano, & B. Marchesi (Eds.), New developments in anxiety disorders. London:
IntechOpen https://doi.org/10.5772/64959.
Sarro, G. D., Chimirri, A., Sarro, A. D., Gitto, R., Grasso, S., & Zappalà, M. (1995).
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2
mice. European Journal of Medicinal Chemistry, 30(12), 925–929. https://doi.org/10.1016/
0223-5234(96)88311-5.
An introduction to benzodiazepines and benzothiazepines 7
Schmitz, A. (2016). Benzodiazepine use, misuse, and abuse: a review. Mental Health Clinician,
6(3), 120–126. https://doi.org/10.9740/mhc.2016.05.120.
Schütz, H. (1982). Benzodiazepines (1st ed.). Berlin Heidelberg: Springer-Verlag https://
doi.org/10.1007/978-3-642-68426-5.
Sternbach, L. H. (1979). The benzodiazepine story. Journal of Medicinal Chemistry, 22(1), 1–7.
https://doi.org/10.1021/jm00187a001.
Sternbach, L. H., & Reeder, E. (1961). Quinazolines and 1,4-benzodiazepines. II. Rearrange-
ment of 6-chloro-2-chlormethyl-4-phenylquinazoline 3-oxide into 2-amino derivatives
of 7-chloro-5-phenyl-3H-1,4-benzodiazepine 4-oxide.Journal of Organic Chemistry,26(4),
1111–1118. https://doi.org/10.1021/jo01063a034.
Wang, P., Eshaq, R. S., Meshul, C. K., Moore, C., Hood, R. L., & Leidenheimer, N. J. (2015).
Neuronal gamma-aminobutyric acid (GABA) type A receptors undergo cognate ligand
chaperoning in the endoplasmic reticulum by endogenous GABA. Frontiers in Cellular
Neuroscience, 9, 188. https://doi.org/10.3389/fncel.2015.00188.
Zakusov, V. V., Ostrovskaya, R. U., Kozhechkin, S. N., Markovich, V. V., Molodavkin, G. M.,
& Voronina, T. A. (1977). Further evidence for GABA-ergic mechanisms in the action
of benzodiazepines. Archives Internationales De Pharmacodynamie Et De Therapie, 229(2),
313–326.
Non-Print Items
Abstract
This chapter briefly explains the history, mechanism of action, and medical applications
of benzodiazepines and benzothiazepines.
Keywords
Benzodiazepines; Benzothiazepines; GABAA receptors; CNS drugs.
CHAPTER TWO
Structural features of
1,4-benzodiazepines
Farzad Zamania, Fatemeh M. Arlanb, Ramin Javahershenasc,
Masoud Yarmohammadid, Rajender S. Varmae and
Esmail Doustkhahf
a
SANKEN, Osaka University, Mihogaoka, Ibaraki-shi, Osaka, Japan
b
Department of Chemistry, Academic Center for Education, Culture and Research, Urmia, Iran
c
Department of Organic Chemistry, Urmia University, Urmia, Iran
d
Faculty of Mechanical Engineering-Energy Division, K.N. Toosi University of Technology, Tehran, Iran
e
Regional Centre of Advanced Technologies and Materials, Czech Advanced Technology and Research
Institute, Palacký University in Olomouc, Olomouc, Czech Republic
f
Koç University Tüpraş Energy Center (KUTEM), Department of Chemistry, Koç University, Istanbul,
Turkey
Chapter outline
2.1 Introduction 9
2.2 Chemical structural variations of 1,4-benzodiazepines 11
2.2.1 1,4-Benzodiazepinones 13
2.2.2 Fused 1,4-benzodiazepines 15
2.3 Conformational studies of 1,4-benzodiazepines 20
2.3.1 Conformational status of 1,4-benzodiazepin-2-ones 21
2.3.2 Conformational status 1,4-benzodiazepine-2,5-diones 24
2.4 Polarity and charge distribution of 1,4-benzodiazepines 26
2.5 1,4-Benzothiazepines 28
2.6 Conclusion 29
References 29
2.1 Introduction
Benzodiazepines and benzothiazepines are two pharmaceutically im-
portant heterocyclic compounds where a benzene ring is fused to either a
diazepine or a thiazepine ring, respectively (Saha et al., 2015). The position
of heteroatoms in the seven-membered ring determines the type and the
chemistry of these cyclo-condensed compounds. According to IUPAC,
when a heterocyclic ring is fused with a benzene unit, it has to be indicated
by the “benzo” prefix. The numbering of benzodiazepines and benzoth-
iazepines should be started from the immediate heteroatom adjacent to the